Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Bradley Canino has joined the firm’s Healthcare equity research department as a ...

Universal Health Services beat Q2 earnings and raised full-year guidance, but growth concerns in behavioral health weighed on ...

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...

Party in the city where the heat is on All night, on the beach till the break of dawn Welcome to Miami” Will Smith’s 1998 ode to South Beach is probably playing all day in LeBron James’ ear as the Los ...

Owns Los Angeles Times, inventor of cancer drug Abraxane, which is used to treat pancreatic cancer. Would go on to sell to ...

Progressive policies have gained momentum as democratic-socialist candidates win primaries in New York and Minneapolis, ...

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing ...

Inside the seductive, dangerous lifestyle of the art world’s power players—and their dramatic implosions after money gets ...

Despite conservative guidance assumptions—including flat year-over-year net new ARR—Guggenheim believes Dynatrace is set up for potential outperformance. The company’s high exposure to secular themes ...

Kalamata combines technology, data science, experience, and common sense to provide fast, simple, and trusted online financing options to small- and medium-sized businesses across the nation to help ...

Liverpool Cathedral has made history as the first cathedral in the UK and Europe to join the Bloomberg Connects App, joining ...

Live Updates Live Coverage Has Ended Monday Wrap-up 4:03 pm The Vanguard S&P 500 ETF closed at 585.46 Monday, down 0.02%.